Prenetics Global Limited (PRE)
- Previous Close
5.87 - Open
6.12 - Bid 5.77 x 100
- Ask --
- Day's Range
5.95 - 6.12 - 52 Week Range
2.85 - 15.00 - Volume
29,012 - Avg. Volume
126,650 - Market Cap (intraday)
72.692M - Beta (5Y Monthly) -0.28
- PE Ratio (TTM)
-- - EPS (TTM)
-4.83 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
60.00
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
www.prenetics.com320
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PRE
Performance Overview: PRE
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRE
Valuation Measures
Market Cap
70.37M
Enterprise Value
-39.00
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.98
Price/Book (mrq)
0.34
Enterprise Value/Revenue
-0.01
Enterprise Value/EBITDA
0.26
Financial Highlights
Profitability and Income Statement
Profit Margin
-288.48%
Return on Assets (ttm)
-11.56%
Return on Equity (ttm)
-24.87%
Revenue (ttm)
21.74M
Net Income Avi to Common (ttm)
-54.35M
Diluted EPS (ttm)
-4.83
Balance Sheet and Cash Flow
Total Cash (mrq)
57.63M
Total Debt/Equity (mrq)
1.13%
Levered Free Cash Flow (ttm)
7.67M